Cambridge Healthtech Institute

This conference is part of the Molecular Med TRI-CON 2012 event on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. Advance registration discounts ends on January 13.

Dr. Williams will present on evidentiary standards for surrogate endpoints, genetic testing & CDx.

CHI’s Bioinformatics & Cancerinformatics conference is a new program being held at the Molecular Med TRI-CON 2012 on Feb. 21-23 at the Moscone in San Francisco. This conference is part of the many program options available at the Tri-Conference.

Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum.

CHI confirms new speakers for its keynote session on cancer clinical trials in the era of personalized medicine lead by Roche Holding AG, UCSF Helen Diller Family Comprehensive Cancer Center, and Samuel Oschin Comprehensive Cancer Institute.

Cambridge Healthtech Institute just adds an interactive panel discussion to take place at its Integrated R&D Informatics & Knowledge Management conference on Feb. 21-23, 2012, San Francisco, CA.

Cambridge Healthtech Institute’s (CHI) BioPharma Strategy Series is proud to present the first conference on Phase III Clinical Trials: Strategic Decisions for Successful Drugs to be held in Philadelphia, PA on March 12-13, 2012.

Discussions led by industry experts, such as Malcolm Young (e-Therapeutics), Jeremy Jenkins (Novartis), and John Burke (Boehringer Ingleheim) will address the implementation of de-risking approaches into the corporate organization.

Make plans to join over 300 of your colleagues. The registration discount deadline is approaching. If you Register by December 2 you will save up to $200.

CHI’s Oncology Clinical Trials conference will highlight three Xalkori case studies by Pfizers’ Hakan Sakul, Ph.D., Keith Wilner, Ph.D., and Erling Thor Donnelly, Ph.D., R.A.C. This conference is part of the Molecular Medicine Tri-Conference.